课题基金 / 基金详情

Development of Off-the-shelf Completely Biological Small-Diameter Blood Vessel wi

Development of Off-the-shelf Completely Biological Small-Diameter Blood Vessel wi
现成的全生物小直径血管的开发
批准号:
8497217
负责人:
Feng Zhao
金额:
$41.01万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-08 至 2016-06-30

项目摘要

项目成果

Feng Zhao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Vascular grafts are in great demand because coronary artery diseases cause 12 million deaths in the world each year and account for half of all deaths in the United States. Despite the successful replacement of large-diameter blood vessels with non-biodegradable polymeric materials, critical issues remain in the creation of coronary heart disease-related small vascular grafts. So far no biomaterials and cel-based tissue- engineered blood vessel (TEBV) can meet the urgent needs of patients for coronary artery substitutes. The objective of this project is to develop a cell sheet engineering strategy potentially suitable for the production of a completely biological and mechanically strong off-the-shelf small-diameter vascular graft in large scale by manipulating human stem cells with biomimetic microenvironmental parameters. Our central hypothesis is that the well-defined biomimetic microenvironments composed of physiological-relevant low O2 concentration and hydrodynamic flows would effectively control the fate of human stem cells, enabling the reproducible production of a mechanically strong TEBV. Our goal is to engineer a small-diameter blood vessel that mimics the three-dimensional cellular organization in the natural blood vessel and can be used as allografts by any patient without time concerns. Aim I: Establish a robust off-the-shelf TEBV manufacturing scheme. Aim II: Evaluate the regeneration process and long-term patency of the TEBV in a rat abdominal model. Aim III: Evaluate the immune response of the TEBV as an allograft in an immune competent rat abdominal artery model. This research will establish a robust off-the shelf small-diameter TEBV fabrication strategy using stem cells. Upon completion, this novel cell sheet-based strategy will overcome the limitations of current biomaterial- and cell-based approaches to provide a completely biological small-diameter vascular graft that can sustain the high blood pressure, stimulate the functional vascular tissue regeneration, and induce integration by the host tissue in vivo.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1089/ten.tec.2015.0465
发表时间: 2016-03
期刊: Tissue engineering. Part C, Methods
影响因子: --
作者: [Emily R. Shearier;Qi Xing;Zichen Qian;F. Zhao]
通讯作者: Emily R. Shearier;Qi Xing;Zichen Qian;F. Zhao
DOI: 10.1038/srep04706
发表时间: 2014-04-16
期刊: Scientific reports
影响因子: 4.6
作者: [Xing Q, Yates K, Vogt C, Qian Z, Frost MC, Zhao F]
通讯作者: Zhao F
Nitric oxide regulates cell behavior on an interactive cell-derived extracellular matrix scaffold.
一氧化氮调节互动细胞衍生的细胞外基质支架上的细胞行为。
DOI: 10.1002/jbm.a.35524
发表时间: 2015-12
期刊: Journal of biomedical materials research. Part A
影响因子: --
作者: [Xing Q, Zhang L, Redman T, Qi S, Zhao F]
通讯作者: Zhao F
DOI: 10.1021/acsami.5b07386
发表时间: 2015-10
期刊: ACS applied materials & interfaces
影响因子: 9.5
作者: [Qi Xing;Zichen Qian;B. Kannan;Mitchell Tahtinen;F. Zhao]
通讯作者: Qi Xing;Zichen Qian;B. Kannan;Mitchell Tahtinen;F. Zhao
Engineered Anisotropic and Vascularized Human Cardiac Patch
Engineered Anisotropic and Vascularized Human Cardiac Patch
Engineered Anisotropic and Vascularized Human Cardiac Patch
Engineered Anisotropic and Vascularized Human Cardiac Patch
海外基金